110 related articles for article (PubMed ID: 12372926)
1. Hemostasis and fibrinolysis factors in first-degree relatives of patients with Type 2 diabetes without hypertension.
Trifiletti A; Lasco A; Scamardi R; Cincotta M; Gaudio A; Barbera N; Frisina N
Pathophysiol Haemost Thromb; 2002; 32(3):127-30. PubMed ID: 12372926
[TBL] [Abstract][Full Text] [Related]
2. The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
Chudý P; Kotuličová D; Staško J; Kubisz P
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):493-8. PubMed ID: 21519232
[TBL] [Abstract][Full Text] [Related]
3. Increased prothrombin fragment 1 + 2 and D-dimer in first-degree relatives of type 2 diabetic patients. Prethrombotic state in relatives of type 2 diabetic patients.
Fernández-Castañer M; Camps I; Fernández-Real JM; Domenech P; Martínez-Brotons F
Acta Diabetol; 1996 Jul; 33(2):118-21. PubMed ID: 8870813
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
Herlihy OM; Barrow BA; Grant PJ; Levy JC
Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
[TBL] [Abstract][Full Text] [Related]
5. Haemostatic variables in arterial hypertension.
Trifiletti A; Barbera N; Pizzoleo MA; Lasco A; Lucifora S; Leone G; Soraci S; Pedullà M; Frisina N
Haemostasis; 1995; 25(5):237-40. PubMed ID: 7489962
[TBL] [Abstract][Full Text] [Related]
6. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
[TBL] [Abstract][Full Text] [Related]
7. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic risk factor clustering and insulin resistance in healthy male relatives of men with intermittent claudication.
Parry DJ; Grant PJ; Scott DJ
Br J Surg; 2006 Mar; 93(3):315-24. PubMed ID: 16498597
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction.
Knudsen EC; Seljeflot I; Abdelnoor M; Eritsland J; Mangschau A; Müller C; Arnesen H; Andersen GØ
J Thromb Haemost; 2011 Aug; 9(8):1468-74. PubMed ID: 21624046
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
12. Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease.
Marzano AV; Tedeschi A; Polloni I; Crosti C; Cugno M
Clin Exp Immunol; 2013 Jan; 171(1):76-81. PubMed ID: 23199326
[TBL] [Abstract][Full Text] [Related]
13. Haemostatic parameters in patients with primitive venous hypertension.
Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Attina A; Soraci S; Bagnato L; Barbera N
Panminerva Med; 1997 Jun; 39(2):100-2. PubMed ID: 9230618
[TBL] [Abstract][Full Text] [Related]
14. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
[TBL] [Abstract][Full Text] [Related]
15. [Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes].
Głowińska B; Urban M; Koput A; Galar M
Przegl Lek; 2003; 60(1):12-7. PubMed ID: 12884639
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
[TBL] [Abstract][Full Text] [Related]
17. Haemostatic factors and intraluminal thrombus thickness in abdominal aortic aneurysm. Is secondary fibrinolysis relevant?
Siennicka A; Drozdzynska M; Chelstowski K; Cnotliwy M; Jastrzebska M
J Physiol Pharmacol; 2013 Jun; 64(3):321-30. PubMed ID: 23959729
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity.
Umpaichitra V; Hussain MM; Castells S
Pediatr Res; 2005 Sep; 58(3):483-7. PubMed ID: 15901895
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.
Folsom AR; Aleksic N; Park E; Salomaa V; Juneja H; Wu KK
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):611-7. PubMed ID: 11304480
[TBL] [Abstract][Full Text] [Related]
20. Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study.
Catena C; Colussi G; Fedrizzi S; Sechi LA
J Hypertens; 2013 Oct; 31(10):2077-84. PubMed ID: 24107736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
